ANN ARBOR, MI, Blue Arbor Technologies, a company developing novel neuromuscular interfaces and next-generation prosthetic control solutions for people with limb loss, announced the close of its $10.5 million Series A financing round.
Blue Arbor Technologies, Inc., a company developing novel neuromuscular interfaces and next-generation prosthetic control solutions for people with limb loss, announced the close of its $10.5 million Series A financing round. The Series A was led by Blue Arbor's strategic partner Ottobock, the global leader in prosthetics, neuro-orthotics, and wearable human bionics.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.